NOVO-NORDISK A/S (NY:NVO)
69.52
+0.38 (0.55%)
| NOVO-NORDISK A/S (NY:NVO) Delayed : |
| Previous Close |
$69.14 |
|
52 Week High |
$85.00 |
|
| Open |
$68.84 |
|
52 Week Low |
$41.35 |
| Day High |
$70.36 |
|
P/E |
N/A |
| Day Low |
$68.84 |
|
EPS |
$0.00 |
| Volume |
1,013,299 |
|
|
|
| More NVO Info:
Chart
SEC Filings
Profile
Historical
Options
|
StreetInsider Reports on NVO by Category
-
Feb 3, 2010 06:55 AM
Novo Nordisk Has High Hopes for Diabetes Blockbuster
-
Feb 2, 2010 04:24 PM
Novo Nordisk A/S Q4 2009 Earnings Call Transcript
-
Jan 31, 2010 10:11 AM
China Biotech in Review: More Money Raised in China IPOs in 2009 than in the U.S.
-
Jan 31, 2010 10:02 AM
Novo Nordisk Awaits China Approval of Diabetes Treatment
-
Jan 26, 2010 11:50 AM
Analyst Upgrades, Downgrades and Initiations: AMLN, CI, CTXS, HSY, KRA, TSCO, TXN ...
View All Blogs
Comments on recent NVO articles
Comments on NVO
No comments are currently available.
on Jul 23, 2009
at 03:37 PM Victoza vs Byetta I was moved on to Byetta from insulin in 2008 for a period of 9 months. Everything was fine for 7 months and I lost 42 pounds in weight and my glucoze control was excellent. Unfortunately, after 7 months my glucoze levels increased dramatically and my weight started to increase once again and after taking Byetta for 9 months I had to go back to insulin once again and my weight has increased to a higher level than it was when I started Byetta.although my glucoze levels have once again come under control. I have today been introduced to Victoza by my diabetic consultant and I hope to be accepted to receive this new product. I believe that the more people that are able to try these new items the better and more accurate studies will become. Who knows, with us being fortunate enough to try these new products one day there will be total control for all!
Article: Novo Nordisk's (NVO) Victoza Returns More Promising Results Than Lilly's (LLY)/Amylin's (AMLN) Byetta
on Jul 8, 2009
at 06:21 PM Victoza Vs Byetta one study, doesnt mean anything. I have been on Byetta for 3 years, my glucose control is excellent
Article: Novo Nordisk's (NVO) Victoza Returns More Promising Results Than Lilly's (LLY)/Amylin's (AMLN) Byetta
on Jun 30, 2009
at 09:05 AM NVO Novartis is not NVO! You have mixed up two companies in this headline and Novo (NVO) is not the correct stock.
Article: Medarex (MEDX) Will Receive Milestone Payment from Novartis (NVO) for FDA Approval of Ilaris